Early Treatment with Sotrovimab for Covid-19. Reply
N Engl J Med
.
2022 Apr 14;386(15):1481.
doi: 10.1056/NEJMc2201606.
Epub 2022 Mar 16.
Authors
Adrienne E Shapiro
1
,
Anil Gupta
2
Affiliations
1
Fred Hutchinson Cancer Research Center, Seattle, WA aeshapir@uw.edu.
2
William Osler Health Centre, Toronto, ON, Canada.
PMID:
35294999
DOI:
10.1056/NEJMc2201606
No abstract available
Publication types
Letter
Comment
MeSH terms
Antibodies, Monoclonal, Humanized / therapeutic use
Antibodies, Neutralizing
COVID-19 Drug Treatment*
Humans
Substances
Antibodies, Monoclonal, Humanized
Antibodies, Neutralizing
sotrovimab